Occult Hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: Clinical significance

Liver Transplantation

Volumn 10, Issue 3, 2004, Pages 356-362

  Ghisetti, Valeria ^a   Marzano, Alfredo ^a   Zamboni, Fausto ^a   Barbui, Anna ^a   Franchello, Alessandro ^a   Gaia, Silvia ^a   Marchiaro, Giovanna ^a   Salizzoni, Mauro ^a   Rizzetto, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DELTA AGENT HEPATITIS; DNA DETERMINATION; DRUG RESPONSE; FEMALE; FOLLOW UP; GENE MAPPING; GRAFT REJECTION; HEPATITIS B; HEPATITIS G; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYMPHOCYTE; MALE; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; SEROLOGY; VACCINATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; AGED; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HOST VS GRAFT REACTION; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; TREATMENT OUTCOME;

EID: 1642304817     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20093     Document Type: Article

References (33)

1. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: A hidden menace? Hepatology. 2001 Jul;34(1):204-206.
2. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "oCcult"? Hepatology. 2001 Jul;34(1):194-203.
3. Lok AS. Hepatitis B infection: Pathogenesis and management. J Hepatol. 2000;32 Suppl 1:89-97.
4. Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology. 1991 Jul;14(1):56-63.
5. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology. 1993 Dec;18(6):1313-1318.
6. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 1998 May;27(5):1377-1382.
7. Lew YY, Michalak TI. In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J Virol. 2001 Feb;75(4):1770-1782.
8. Michalak TI. Occult persistence and lymphotropism of hepadnaviral infection: Insights from the woodchuck viral hepatitis model. Immunol Rev. 2000 Apr;174:98-111.
9. Coffin CS, Michalak TI. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest. 1999 Jul;104(2):203-212.
10. Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P, et al. Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology. 1999 Mar;29(3): 928-938.
11. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999 Apr 30;284(5415): 825-829.
12. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996 Oct;2(10):1104-1108.
13. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 1996 Sep 1;98(5):1185-1194.
14. Chan HL, Tsang SW, Leung NW, Tse CH, Hui Y, Tam JS, et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol. 2002 May;97(5):1211-1215.
15. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002 Aug;2(8):479-486.
16. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002 Jul;9(4):243-257.
17. Raimondo G. Occult hepatitis B virus infection and liver disease: Fact or fiction? J Hepatol. 2001 Mar;34(3):471-473.
18. Raimondo G, Balsano C, Craxi A, Farinati F, Levrero M, Mondelli M, et al. Occult hepatitis B virus infection. Dig Liver Dis. 2000 Dec;32(9):822-826.
19. Yotsuyanagi H, Yasuda K, Moriya K, Shintani Y, Fujie H, Tsutsumi T, et al. Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion. 2001 Sep;41(9):1093-1099.
20. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol. 2002 Nov;40(11):4068-4071.
21. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N ENgl J Med. 1999 Jul 1;341(1):22-26.
22. Munoz SJ. Use of Hepatitis B Core antibody-positive donors for Liver transplantation. Liver Transpl 2002, 8(10):S82-S87.
23. Rizzetto M. Transmission of hepatitis B infection from hepatitis B core antibody - positive livers: Background and prevention. Liver Transpl. 2001 Jun;7(6):518-520.
24. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991;13:619-626.
25. Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Iwaki Y, Sysyn G, et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol. 1990 Sep;137(3):667-676.
26. Samuel D, Muller D, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with hepatitis B surface antigen. New Engl J Med 1993;329:1842-1847.
27. Rizzetto M, Macagno S, Chiaberge E, Verme G, Negro F, Marinucci G, et al. Liver transplantation in hepatitis delta virus disease. Lancet. 1987 Aug 29;2(8557):469-471.
28. Marzano A, Gaia S, Ciardo V, Premoli A, Ghisetti V, Salizzoni M, et al. Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: A single center experience. Transpl. Proc. 2003; 35(3):1020-1021.
29. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA patients with chronic HBV infection. Hepatology, 2000;31(2):507-512.
30. Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yama K, et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology, 2003; 37(5):1172-1179.
31. Kao JH, Chen PJ, Lai MY, Chen DS. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection, J Med Virol. 2002 Oct;68(2):216-220.
32. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 2001 Nov;34(5):1027-1034.
33. Blackberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self limited infection persisting for 30 years without sequence variation. J Hepatol. 2000 Dec;33(6):992-997.